Pharmaceutical Chemicals Market Size, Share & Analysis Report, 2023-2032
The global pharmaceutical chemicals market size was exhibited at USD 120.44 billion in 2022 and is projected to hit around USD 239.15 billion by 2032, growing at a CAGR of 3.90% during the forecast period 2023 to 2032.
Crucial factors accountable for market growth are:
The healthcare industry is flourishing on the back of increased disposable income of urban population and escalating percentage of geriatrics in the world’s population. Consequently, the demand for pharmaceuticals is on the rise, providing a strong traction to the global pharmaceutical chemicals market. Forming the basic ingredients for the manufacturing of medicines, the market for pharmaceutical chemicals functions under high safety standards
Rise in non-communicable diseases, aging population, life expectancy, improved income level a larger masses in BRICS nations, increased government expenditure on healthcare, and ongoing research and development are some of the key trends behind the growth of the pharmaceutical chemicals market.
Geographically, North America accounted for the maximum, 50.9%, share of the total demand in the global pharmaceutical chemicals market in 2022. The strength of the demand from North America can be ascribed to the increase in demand from consumer base in the region, primarily from the developed countries of the U.S. and Canada. The U.S. houses the headquarters and prominent shareholders of some of the leading companies operating in this market, which is also in the favor of the North America pharmaceutical chemicals market. Europe also served a prominent share of demand at 28.1% in the global pharmaceutical chemicals market in 2022 and is expected to flourish further during the forecast period. That being said, the analysts of the report have highlighted Asia Pacific as a region with tremendous opportunities, projecting the demand from the region to increment at an above-average CAGR of 11.7% during the forecast period of 2023 to 2032. The global market share of Latin America and Middle East and Africa is expected to increase, but at a slow pace in the near future.
Pharmaceutical chemicals Market Segmentation
| Product Type | Application Type |
|
Basic building blocks Advanced intermediates Active ingredients |
Cardiovascular Neurology Oncology Infectious diseases Metabolic system Diabetes Respiratory diseases Gastrointestinal diseases Musculoskeletal diseases Other
|
Pharmaceutical chemicals Market Key Players And Regions
| Companies Profiled | Regions Covered |
|
BASF Lonza Porton Fine Chemicals Dishman Lanxess Johnson Matthey Vertellus Holdings Jubilant Life Sciences Hikal Abbott |
North America Europe Asia-Pacific Latin America Middle East & Africa (MEA)
|
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Pharmaceutical Chemicals Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Pharmaceutical Chemicals Market
5.1. Covid-19: Pharmaceutical Chemicals Industry Impact
5.2. Pharmaceutical Chemicals Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Pharmaceutical Chemicals Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Pharmaceutical Chemicals Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Pharmaceutical Chemicals Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing generic population
6.1.1.2. Increasing demand for preventive healthcare
6.1.2. Market Restraints
6.1.2.1. Strict environmental standard and high cost of raw materials
6.1.3. Market Opportunities
6.1.3.1. Emerging markets
Chapter 7. Global Pharmaceutical Chemicals Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Pharmaceutical Chemicals Market Revenue by Market Players (2018 - 2020)
7.1.1.2. Pharmaceutical Chemicals Market Revenue Market Share by Market Players (2018 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Pharmaceutical Chemicals Market, By Product
8.1. Pharmaceutical Chemicals Market, by Product, 2018-2032
8.1.1. Basic building blocks
8.1.1.1. Market Revenue and Forecast (2018-2032)
8.1.2. Advanced intermediates
8.1.2.1. Market Revenue and Forecast (2018-2032)
8.1.3. Active ingredients
8.1.3.1. Market Revenue and Forecast (2018-2032)
Chapter 9. Global Pharmaceutical Chemicals Market, By Application
9.1. Pharmaceutical Chemicals Market, by Application, 2018-2032
9.1.1. Cardiovascular
9.1.1.1. Market Revenue and Forecast (2018-2032)
9.1.2. Neurology
9.1.2.1. Market Revenue and Forecast (2018-2032)
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast (2018-2032)
9.1.4. Infectious diseases
9.1.4.1. Market Revenue and Forecast (2018-2032)
9.1.5. Metabolic system
9.1.5.1. Market Revenue and Forecast (2018-2032)
9.1.6. Diabetes
9.1.6.1. Market Revenue and Forecast (2018-2032)
9.1.7. Respiratory diseases
9.1.7.1. Market Revenue and Forecast (2018-2032)
9.1.8. Gastrointestinal diseases
9.1.8.1. Market Revenue and Forecast (2018-2032)
9.1.9. Musculoskeletal diseases
9.1.9.1. Market Revenue and Forecast (2018-2032)
9.1.10. Other
9.1.10.1. Market Revenue and Forecast (2018-2032)
Chapter 10. Global Pharmaceutical Chemicals Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product(2018-2032)
10.1.2. Market Revenue Forecast by Application (2018-2032)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2018-2032)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2018-2032)
10.2. Europe
10.2.1. Market Revenue Forecast by Product (2018-2032)
10.2.2. Market Revenue Forecast by Application (2018-2032)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2018-2032)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2018-2032)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2018-2032)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2018-2032)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product (2018-2032)
10.3.2. Market Revenue Forecast by Application (2018-2032)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2018-2032)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2018-2032)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2018-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2018-2032)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product (2018-2032)
10.4.2. Market Revenue Forecast by Application (2018-2032)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2018-2032)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2018-2032)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product (2018-2032)
10.5.2. Market Revenue Forecast by Application (2018-2032)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2018-2032)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2018-2032)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2018-2032)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2018-2032)
Chapter 11. Company Profiles
11.1. BASF
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2018-2020)
11.1.4. Recent Developments and Strategies
11.2. Lonza
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2018-2020)
11.2.4. Recent Developments and Strategies
11.3. Porton Fine Chemicals
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2018-2020)
11.3.4. Recent Developments and Strategies
11.4. Dishman
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2018-2020)
11.4.4. Recent Developments and Strategies
11.5. Lanxess
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2018-2020)
11.5.4. Recent Developments and Strategies
11.6. Johnson Matthey
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2018-2020)
11.6.4. Recent Developments and Strategies
11.7. Vertellus Holdings
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2018-2020)
11.7.4. Recent Developments and Strategies
11.8. Jubilant Life Sciences
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2018-2020)
11.8.4. Recent Developments and Strategies
11.9. Hikal
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2018-2020)
11.9.4. Recent Developments and Strategies
11.10. Abbott
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2018-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers